# FEBUXOSTAT
> **ANDA207293** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2023-09-28
## Drug
- **FDA Application Number:** ANDA207293
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FEBUXOSTAT
- **Generic name:** FEBUXOSTAT TABLETS 40 MG
- **Active ingredients:** FEBUXOSTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2023-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207293)
---
*AI Analytics · CC0 1.0*